anty viral

VELAKAST TABLET 28 Tablets – Sofosbuvir 400 mg + Velpatasvir 100 mg | Pharmaceutical Exporter India to Australia VELAKAST Tablet 1 Bottle Sofosbuvir 400 mg + Velpatasvir 100 mg Tablet 28 Tablets PRIME CARE IMPEX welcomes pharmaceutical export enquiries from India to overseas customers and businesses looking for product information, specifications and pharmaceutical export services for the Australian market. Pharmaceutical Export Services from India to Australia PRIME CARE IMPEX supports India to Australia pharmaceutical export queries for customers and businesses across key Australia locations including: Sydney. Melbourne. Brisbane Perth Perth Adelaide Canberra. Gold Coast Our team will be able to assist with product related information, packaging details, commercial enquiries and export documentation requirements as applicable within Indian and Australian pharmaceutical regulations. VELAKAST Tablet Product Information Product VELAKAST Tablet Packing Size28 Tabs Bottle1 Fl. Active Ingredient 1 Sofosbuvir 400mg Active Ingredient 2 Velpatasvir 100 mg Product Category Antiviral medicine Export India Origin Target Market Australia Type of Inquiry Pharmaceutical Export / Product Inquiry. Product Description for VELAKAST Tablet VELAKAST Tablet is a combination medicine. The active pharmaceutical ingredients of VELAKAST Tablet are Sofosbuvir 400 mg and Velpatasvir 100 mg. Sofosbuvir and velpatasvir are direct-acting antivirals for the treatment of hepatitis C infection. The conditions of product registration, prescription, import and distribution may vary between India and Australia. Australian customers, importers and healthcare businesses should check the applicable requirements with the relevant Australian authorities and qualified professionals before importing, supplying or using prescription medicines. Pharmaceuticals Export Enquiries India – Australia For product and export related enquiries please contact: PRIME CARE IMPEX Looking for Indian Pharmaceutical Supplier for Australia. We welcome enquiries for pharmaceutical exports from India from customers in: Sydney • Melbourn • Brisbane • Adelaide • Perth • Gold Coast • Canberra We can talk about product specs, packaging, documentation, availability enquiries and international pharmaceutical export requirements, in compliance with applicable regulations. Pharmaceutical Export Services to Australia from India PRIME CARE IMPEX assists for international pharmaceutical export queries from India to overseas markets. Information about our services may include: Australian enquiries; Specifications of pharmaceutical products Active ingredient and dose information Indian Pharma Exporter to Australia PRIME CARE IMPEX is an India based pharmaceutical export inquiry company helping international customers to know more about pharmaceutical products manufactured or supplied from India. If you want export and import data and product specifications of VELAKAST Tablet 28 Tablets, please contact us. We can guide you through export registration process for VELAKAST Tablet 28 Tablets and other products. Australia Pharmaceutical Supplier – Key Locations Our pharmaceutical export enquiries for Australia include customers and businesses in major cities and regions including: Sydney, Australia Melbourne, Australia Brisbane, Australia Perth, Australia Adelaide Australia Canberra, Australia Gold Coast, Australia No matter if your inquiry is from Sydney, Melbourne, Brisbane or other Australian location, PRIME CARE IMPEX can provide product and export related information for further commercial discussion. VELAKAST Tablet Australia | Pharmaceutical Exporter from India to Australia About the meta description for SEO VELAKAST Tableta 28 Tabletas que contienen Sofosbuvir 400 mg + Velpatasvir 100 mg. For export enquiries and product information Pharma Prime Care Impex India to Australia please contact. About PRIME CARE IMPEX PRIME CARE IMPEX promotes International Pharmaceutical export enquiries from India and provides product, packaging and export related information to prospective overseas customers. For pharmaceutical export enquiries from Australia including Sydney, Melbourne, Brisbane, Perth, Adelaide, Canberra and Gold Coast contact our team for product information and commercial discussions. Contact PRIME CARE IMPEX Official Website : medicineexporterfromindia.com Corporate Email raakeshkashiwar@gmail.com Phone / Whats App : +91 9673008130 Whats App +91 9673008130

Telura 300mg/300mg/600mg Pharmaceutical Supplier in UK Telura 300mg/300mg/600mg Tablet is composed of Tenofovir Disoproxil Fumarate, Lamivudine and Efavirenz. Packaging: 30 tablets, 1 bottle. Prime Care Impex Prime Care Impex is an India based pharmaceutical exporter supporting international pharmaceutical sourcing and export queries. We support UK enquiries including London, Birmingham, Manchester, Glasgow, Liverpool and Leeds. Product Specifications Product: Telura 300mg/300mg/600mg Tabs Composition: Tenofovir Disoproxil Fumarate + Lamivudine + Efavirenz Dosage Form: Tablet Pack Size: 30 Tablets 1 bottle Packing: Supplies from India Service: Export & Sourcing of Pharmaceutical Enquiries India To Uk Pharma Export Services We provide pharmaceutical export services from India to UK for licensed buyers, importers, distributors and pharmaceutical companies. Availability of the product, documentation, packaging and export requirements are confirmed for the specific inquiry and the regulations that apply. We support pharmaceutical sourcing enquiries for: London · Birmingham · Manchester • Glasgow, • Lids • Liverpool Telura supplier UK. Telura 300mg/300mg/600mg supplier UK. Telura pharmaceutical sourcing India. Prime Care Impex Contact. Prime Care Impex 🌐 www.medicineexporterfromindia.com 📧 raakeshkashiwar@gmail.com 📱 +91 9673008130 💬 WhatsApp: +91 9673008130 Telura 300mg supplier UK, Telura pharmaceutical supplier UK, pharmaceutical exporter India, pharmaceutical supplier UK, pharmaceutical exporter Birmingham, pharmaceutical exporter London, India to UK pharmaceutical export, pharmaceutical sourcing India.

TEFOWELL-300 Tenofovir Disoproxil Fumarate 300 mg Pharmaceutical Exporter India to Australia TEFOWELL-300® Tenofovir Disoproxil Fumarate Tablet 300 mg is an antiviral pharmaceutical formulation containing Tenofovir Disoproxil Fumarate 300 mg. PRIME CARE IMPEX is a Pharmaceutical Export Inquiry in India for Approved Pharmaceutical Purchasers and Companies in Australia. Specifications of the Product Product Name: TEFOWELL-300 (PVA) Active Ingredient: Tenofovir Disoproxil Fumarate Strength: 300mg Preparation: tablets Therapeutic Class: Antiviral Country of Origin India Target Market: AU Inquiry Type:Pharmaceutical procurement and export Tenofovir disoproxil fumarate is an antiviral drug used to treat certain viral infections, including HIV infection and chronic hepatitis B, as described in the applicable prescribing information. Pharmaceutical Export Services, India to Australia PRIME CARE IMPEX provides pharmaceutical export inquiry services from India to Australia for authorised buyers, importers, distributors and pharmaceutical procurement businesses. We welcome enquiries about: Availability of products Pharmaceutical specifications Bulk procurement enquiries Commercial quotes Packaging data Exportdocumentation Shipping & supply questions Pharmaceutical Supplier Australia India to Australia Pharmaceutical Sourcing If you are looking for a pharmaceutical supplier in Australia, Tenofovir Disoproxil Fumarate 300 mg supplier, or a pharmaceutical exporter from India to Australia, PRIME CARE IMPEX can assist with product and export enquiries. We have offices in all major cities in Australia, including: Sydney • Melbourne • Brisbane • Perth • Adelaide • Canberra • Gold Coast Australian importers and distributors should confirm applicable TGA registration, import, licensing and distribution requirements before importing or supplying medicines in Australia. Pharmaceutical Exporter India to Australia PRIME CARE IMPEX provides an international contact point for pharmaceutical buyers seeking products sourced from India. For Australia-bound enquiries, buyers can contact us with the product name, required quantity, destination and procurement requirements. All pharmaceutical imports and supply arrangements should comply with applicable Australian regulatory requirements. Contact PRIME CARE IMPEX PRIME CARE IMPEX Pharmaceutical Exporter from India 🌐 Website: www.medicineexporterfromindia.com 📧 Email: raakeshkashiwar@gmail.com 📱 Phone / WhatsApp: +91 9673008130 WhatsApp: https://wa.me/9673008130 For TEFOWELL-300 Tenofovir Disoproxil Fumarate 300 mg export enquiries, contact PRIME CARE IMPEX for product availability, specifications and commercial information. TEFOWELL-300 Tenofovir Disoproxil Fumarate 300 mg, Tenofovir Disoproxil Fumarate 300 mg supplier Australia, Tenofovir exporter India, pharmaceutical exporter India to Australia, pharmaceutical supplier Australia, pharmaceutical supplier Sydney, pharmaceutical supplier Melbourne, pharmaceutical supplier Brisbane, Tenofovir tablet supplier India, India to Australia pharmaceutical export, pharmaceutical export company India. TEFOWELL-300 Tenofovir 300 mg Supplier | India to Australia Exporter TEFOWELL-300 Tenofovir Disoproxil Fumarate 300 mg export enquiries from India to Australia. Contact PRIME CARE IMPEX for pharmaceutical supply information. URL Slug /tefowell-300-tenofovir-disoproxil-fumarate-300mg-australia/ H1 TEFOWELL-300 Tenofovir Disoproxil Fumarate 300 mg – India to Australia Pharmaceutical Exporter

Create a detailed, professional, SEO-friendly website/blog page for PRIME CARE IMPEX targeting pharmaceutical export enquiries from India to the United Kingdom, especially London and Birmingham. Products SOFOCURE-V – Sofosbuvir 400 mg + Velpatasvir 100 mg Tab UK locations to shoot for: London Birmingham Manchester Liverpool Leeds Glasgow Keywords Use the following keywords naturally throughout the content: Sofocure-V Sofosbuvir 400 mg and Velpatasvir 100 mg Sofosbuvir 400 mg Velpatasvir 100 mg exporter India pharmaceutical exporter India to UK pharmaceutical supplier UK pharmaceutical exporter Birmingham pharmaceutical exporter London India to UK pharmaceutical export services pharmaceutical export company India pharmaceutical supplier Birmingham UK pharmaceutical supplier London UK medicines exporter from India pharmaceutical export inquiry UK Content Structure Build the page with these sections: Include Sofocure-V, Sofosbuvir 400 mg + Velpatasvir 100 mg and UK pharmaceutical exporter keywords. UK pharmaceutical buyers and enquiries from export markets H1 Heading pharmaceutical export to UK from India + Product name. Introductory PRIME CARE IMPEX is a pharmaceutical export company based in India. UK Government backing for legitimate enquiries on pharmaceutical exports. Mention London, Birmingham, Manchester, Liverpool, Leeds and Glasgow naturally. About the Product Sofocure-V contains Sofosbuvir 400 mg and Velpatasvir 100 mg. Add tablet dosage form and antiviral category Provide factual information only. Do not make claims about cure rate, guarantyd results, lowest price or superiority that are not supported. Product Information Include Brand: Sofocure-V Active components: Sofosbuvir 400mg + Velpatasvir 100mg Form: Tablet Class: Antiviral Country of origin INDIAN Target market: United Kingdom / international export enquiries Pharmaceutical Export Services from India to UK PRIME CARE IMPEX support to Describe: About the product Sourcing pharmaceuticals Co-ordination of export documentation Product/Packaging Details Coordination of international shipment Pharmaceutical Enquiries (Business to Business) UK Pharmaceutical Supplier Build an SEO focused section for the keyword “pharmaceutical supplier UK” Advise UK-based organisations on how to approach an India-based pharmaceutical exporter for legitimate business enquiries, whilst guaranteeing compliance with applicable UK import and pharmaceutical regulations. London pharmaceutical exporter Pharmaceutical export Birmingham Pharmaceutical export Manchester Pharmaceutical export Liverpool Pharmaceutical export Leeds Pharmaceutical export Glasgow Pharmaceutical export Don’t stuff keywords. Each section should hold very useful information for pharmaceutical procurement/export enquiries. Pharmaceutical Exports Overview Here’s the general procedure: Product inquiry forms Confirming requirements Review of documents. Regulatory/Import Requirements Check Commercial conversation Export paperwork 3. Coordination of shipment Why Should You Choose PRIME CARE IMPEX? India based pharmaceutical export support International enquiries handling Communication on products Coordinate export documentation Inquiry support for the UK Avoid unsupported claims such as “No.1 exporter”, “100% guaranteed”, “cheapest supplier” or “UK approved” unless you have independent verification. like: Sofocure-V What is Sofocure-V? What are the benefits of Sofocure-V? PRIME CARE IMPEX export of pharmaceuticals from India to the UK? Do you take pharmaceutical enquiries from Birmingham? Are you London based for pharmaceutical enquiries? How does a UK buyer send a pharmaceutical inquiry? What information do I need to provide for an export inquiry? What documents do I need for exporting pharmaceuticals? Are there regulatory requirements that need to be met to import into the UK? How can I contact PRIME CARE IMPEX? Get Involved Include a professional B2B CTA such as: For Sofocure-V and other pharma export inquiry from India to UK contact PRIME CARE IMPEX. Company Information Company: PRIME CARE IMPEX Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone: +91 9673008130 WhatsApp @ +91 9673008130

RIBASURE 200 MG Ribavirin Capsules – Pharmaceutical Export Information for Australia Primary Pharmaceutical Supplier Australia Secondary Keywords: Pharmaceutical Exporter India Australia, Pharmaceutical Export Services India to Australia, Ribavirin Capsules Supplier Australia, Pharmaceutical Supplier Sydney, Pharmaceutical Supplier Melbourne, Pharmaceutical Supplier Brisbane, Australian Pharmaceutical Importer, Pharmaceutical Export Company India RIBASURE 200 MG Ribavirin Capsules RIBASURE 200 MG contains ribavirin, an antiviral pharmaceutical ingredient. RIBASURE 200 MG Ribavirin Capsules are supplied in a bottle containing 140 capsules, subject to the applicable product packaging and manufacturer documentation. Prime Care Impex supports international pharmaceutical export enquiries from India for legitimate business customers seeking product information, commercial details, export documentation, and shipment-related assistance. Pharmaceutical Supplier Australia – Export Enquiry Support Prime Care Impex provides support for pharmaceutical export enquiries from India to Australia. Businesses looking for an India-based pharmaceutical supplier for Australia can contact our team to discuss product requirements and applicable export procedures. Our Australia-focused enquiry coverage can include: Sydney Melbourne Brisbane Perth Adelaide Canberra Hobart Darwin Export availability and supply arrangements depend on applicable Indian export requirements, Australian regulatory requirements, product registration, import permissions, and customer eligibility. India to Australia Pharmaceutical Export Services Prime Care Impex supports pharmaceutical export enquiries from India to Australia for permitted business-to-business pharmaceutical trade. For prescription pharmaceutical products such as ribavirin, Australian customers should confirm applicable requirements concerning product registration, import permissions, licensing, prescription status, customs procedures, therapeutic goods requirements, and other applicable Australian regulations before proceeding with an order. Product Specifications Product Name: RIBASURE 200 MG Ribavirin Capsules Active Ingredient: Ribavirin Strength: 200 mg Dosage Form: Capsules Pack Size: 140 capsules per bottle Product Category: Pharmaceutical / Antiviral Export Origin: India Target Market: Australia Enquiry Type: Pharmaceutical export / business-to-business enquiry Current manufacturer information, batch details, expiry date, shelf life, certificates, packaging specifications, availability, and other technical documentation should be verified against the applicable product documentation before any commercial transaction. Pharmaceutical Export Overview Pharmaceutical exports to Australia require appropriate documentation and compliance with applicable requirements in both the exporting and importing countries. Prime Care Impex receives enquiries from businesses, pharmaceutical companies, distributors, importers, and other eligible organisations interested in sourcing pharmaceutical products from India for permitted international markets. Our Australia-focused export enquiry coverage includes Sydney, Melbourne, Brisbane, Perth, Adelaide, Canberra, Hobart, and Darwin. Pharmaceutical Exporter India for Australia Enquiries Prime Care Impex is an India-based pharmaceutical export company supporting international business enquiries. If you are searching for a pharmaceutical exporter from India to Australia, contact our team with the product name, required quantity, destination, and relevant business information. We can review the enquiry and provide information regarding available export documentation and the appropriate commercial process. Pharmaceutical Supplier Australia – Business Enquiries Businesses searching for a pharmaceutical supplier in Australia or an Indian pharmaceutical exporter supplying the Australian market can contact Prime Care Impex for product-related export enquiries. We support enquiries from Australian pharmaceutical businesses and organisations seeking information about pharmaceutical products sourced from India, subject to applicable regulatory and import requirements. Important Regulatory Notice Ribavirin is a prescription medicine and should only be used under the supervision of an appropriately qualified healthcare professional. This page is intended for pharmaceutical trade and product-information enquiries. It is not medical advice, a prescribing recommendation, or an invitation for individuals to purchase prescription medicines for personal use. Australian importers and other relevant organisations are responsible for ensuring that any proposed import, supply, distribution, or use complies with applicable Australian requirements. Contact Prime Care Impex PRIME CARE IMPEX Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone: +91 9673008130 WhatsApp: +91 9673008130 For India to Australia pharmaceutical export enquiries,

RESOF TOTAL Sofosbuvir 400mg / Velpatasvir 100mg Tablet – Pharma Exporter India to Australia PRIME CARE IMPEX is an India based pharmaceutical exporter, supporting international B2B pharmaceutical sourcing and export enquiries. We help qualified companies and licensed pharmaceutical partners to source pharmaceutical products from India for international markets including Australia. For businesses & organisations in Sydney, Melbourne, Brisbane, Perth, Adelaide, Canberra and other Australian locations, our India to Australia pharmaceutical export services are here for enquiries. RESOF TOTAL Sofosbuvir 400 mg / Velpatasvir 100 mg Tablet Name of Product: RESOF TOTAL Composition: Sofosbuvir 400 mg + Velpatasvir 100 mg Dosage Form : Tablet Product Category: Formulation pharma Country of Origin: India Supply Type: B2B Pharmaceutical Export Request Target Market: Australia / Overseas RESoF TOTAL is a combination of Sofosbuvir 400 mg + Velpatasvir 100 mg. The product information on this page is applicable for B2B pharmaceutical sourcing and export enquiries. Before starting any transaction, check product availability, registration status, import requirements and permitted supply arrangements for the Australian market. Export of medicines from India to Australia PRIME CARE IMPEX provides pharmaceutical export enquiries from India to Australia for qualified international buyers, pharmaceutical companies and authorised business partners. Our export inquiry services can cover: Product Availability Questions Parameters of medicinal products Commercial quote requests Discussions on packaging and quantity Export documentation Shipping info Regulatory documentation, if applicable. Australia’s relationship with importing organisations In Australia there are specific regulatory requirements for therapeutic goods. Businesses wanting to import therapeutic goods into Australia should check with the Therapeutic Goods Administration (TGA) to ensure they meet the applicable requirements before importing or supplying products. Pharmaceutical Supplier Australia – India Export Service If you are looking for Pharmaceutical Vendor in Australia, India pharmaceutical exporter to Australia, pharmaceutical export company India, Sofosbuvir Velpatasvir supplier then PRIME CARE IMPEX can help you with regards to B2B Sourcing. Our team in India can help Australian business customers and organisations with appropriate authorisation with product information and international export enquiries. Details of the Product Specification Information Product Name RESOF Total Active IngredientsVelpatasvir 100 mg + Sofosbuvir 400 mg Dosage Form Tablet Pharmaceutical Category Finished Pharmaceutical Formulation Country of Origin India Export Market Australia / International Inquiry Type B2B Pharmaceutical Sourcing Supplier Location India Destination: Australia Pharmaceutical Export Services To Australia India PRIME CARE IMPEX offers a communication channel for companies searching for Pharmaceutical Sourcing from India. Our general export inquiry process is: Product inquiry forms Verification of product composition Quantity requirements Offer commercial Packaging data Talk of export documentation Destination & Shipping Information Review of regulatory requirement Coordination with import organization Australian importers should verify the relevant regulatory status and import requirements for the specific medicine and intended use before ordering. Pharmaceutical Export Enquiries - All Over Australia We can assist with pharmaceutical export enquiries from major Australian locations including: Sydney • Melbourn • Brisbane • Adelaide • Perth • Canberra. • Gold Coast – •Newcastle • Hobart • Darvin If your business is in Sydney, Melbourne, Brisbane or any other location in Australia, you can contact PRIME CARE IMPEX for a B2B pharmaceutical export inquiry from India. Sofosbuvir 400 mg + Velpatasvir 100 mg Pharmacy Manufacturer RESoF TOTAL is a tablet formulation containing Sofosbuvir 400 mg and Velpatasvir 100 mg. Companies who are interested in sourcing this formulation from India can contact PRIME CARE IMPEX to discuss product availability, quantities, packaging, export documentation and destination requirements. Market-specific product registration and legal supply requirements. Customers in Australia should verify whether the particular product is licensed or otherwise permitted to be imported and supplied in Australia. India Pharmaceutical Exporter to Australia India is a well-known global manufacturing and export market for pharmaceutical. PRIME CARE IMPEX is committed to helping international pharmaceutical sourcing enquiries by linking overseas business customers with product and export information. PRIME CARE IMPEX 🌐 Website: www.medicineexporterfromindia.com 📧 Email: raakeshkashiwar@gmail.com 📱 Phone: +91 9673008130 💬 WhatsApp : +91 9673008130

What is MyHep Tablet (Sofosbuvir 400 mg)? MyHep Tablet 400 mg contains Sofosbuvir 400 mg, a highly effective antiviral medicine used in the treatment of chronic Hepatitis C Virus (HCV) infection. It belongs to a class of medicines known as direct-acting antivirals (DAAs) and is prescribed as part of combination therapy, depending on the HCV genotype and the patient's clinical condition. Modern Hepatitis C treatment with Sofosbuvir has significantly improved cure rates while reducing treatment duration compared with older interferon-based therapies. Many treatment regimens achieve sustained virologic response (SVR), meaning the virus becomes undetectable after treatment when used appropriately under medical supervision. Product Headline MyHep Tablet (Sofosbuvir 400 mg) – Advanced Antiviral Medicine for Chronic Hepatitis C Treatment Product Profile Product Name: MyHep Tablet Generic Name: Sofosbuvir Strength: 400 mg Dosage Form: Oral Tablet Packing: 28 Tablets (1 Bottle) Category: Antiviral Medicine Therapeutic Class: Direct Acting Antiviral (DAA) Primary Use: Treatment of Chronic Hepatitis C Virus (HCV) Infection How Sofosbuvir Works Sofosbuvir works by inhibiting the NS5B RNA-dependent RNA polymerase, an enzyme required for Hepatitis C virus replication. Step-by-step process: Step 1 After oral administration, Sofosbuvir is absorbed into the bloodstream. Step 2 Inside liver cells, it is converted into its active metabolite. Step 3 The active metabolite blocks the viral NS5B polymerase. Step 4 The Hepatitis C virus is unable to replicate effectively. Step 5 The viral load decreases over time, allowing the immune system to clear the infection when the full treatment regimen is completed. tep-by-Step Treatment Process Step 1 – Medical Evaluation Your healthcare provider confirms Hepatitis C infection and assesses liver health. Step 2 – Laboratory Testing Testing may include: HCV RNA Liver function tests Kidney function tests HCV genotype (where applicable) Step 3 – Treatment Selection A suitable antiviral combination regimen is selected. Step 4 – Daily Medication Take MyHep Tablet consistently as directed. Step 5 – Monitoring Periodic blood tests help monitor treatment response and safety. Step 6 – Completion Complete the prescribed course. Step 7 – Follow-Up A follow-up HCV RNA test is typically performed after treatment to evaluate sustained virologic response (SVR). Benefits of MyHep Tablet Modern direct-acting antiviral therapy High cure rates when used in appropriate combination regimens Once-daily dosing Well-established efficacy in recommended patient groups Interferon-free options in many treatment protocols Supports long-term viral clearance when treatment is completed as prescribed Can MyHep Tablet cure Hepatitis C? When used as part of an appropriate treatment regimen prescribed by a healthcare professional, many patients achieve sustained virologic response (SVR), which is considered a functional cure. Can I stop treatment once I feel better? No. Complete the full prescribed course unless your healthcare provider advises otherwise. Can I take MyHep Tablet with food? Yes. It may generally be taken with or without food unless your healthcare provider gives different instructions. Is monitoring necessary? Yes. Regular medical follow-up and laboratory monitoring are important throughout treatment. Why Choose Primecare Impex? Primecare Impex is committed to providing quality pharmaceutical products with a focus on customer support and international supply standards. Highlights include: Pharmaceutical exporter from India Quality-focused sourcing Professional customer support Reliable product handling International supply experience Responsive communication Timely documentation support Contact Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

Myhep DVIR Tablet contains Daclatasvir 60 mg and Sofosbuvir 400 mg film-coated tablets for the treatment of chronic Hepatitis C Virus (HCV) infection. Learn about indications, dosage, mechanism of action, safety, storage, and product information from Primecare IMPEX. Myhep DVIR Tablet Daclatasvir 60 mg + Sofosbuvir 400 mg Film-Coated Tablets Product Overview Myhep DVIR Tablet is a fixed-dose antiviral medicine containing Daclatasvir 60 mg and Sofosbuvir 400 mg. This combination belongs to the class of Direct-Acting Antiviral (DAA) medicines used in the treatment of chronic Hepatitis C Virus (HCV) infection in adults. The combination targets different stages of viral replication, helping reduce the viral load and supporting sustained virologic response (SVR) when prescribed by a qualified healthcare professional. Product Profile Brand Name: Myhep DVIR Tablet Generic Composition Daclatasvir 60 mg Sofosbuvir 400 mg Dosage Form Film-Coated Tablet Strength 60 mg / 400 mg Packing 28 Tablets 1 Bottle Therapeutic Category Direct-Acting Antiviral (DAA) Primary Use Treatment of Chronic Hepatitis C Virus (HCV) Infection Myhep DVIR Tablet is prescribed for the treatment of chronic Hepatitis C Virus infection in adults when recommended by a physician. Depending on viral genotype, liver condition, prior treatment history, and current clinical guidelines, treatment duration and combinations may vary. Healthcare providers typically evaluate: HCV genotype Liver function Viral load Previous treatment history Presence of liver cirrhosis Co-existing medical conditions Potential drug interactions The medicine should only be used under medical supervision. How Myhep DVIR Works Myhep DVIR combines two antiviral medicines that attack different proteins essential for Hepatitis C virus replication. Sofosbuvir Sofosbuvir inhibits the NS5B RNA-dependent RNA polymerase, an enzyme required for viral RNA replication. By blocking this enzyme, viral multiplication is significantly reduced. Daclatasvir Daclatasvir inhibits the NS5A protein. NS5A plays an important role in viral replication and viral assembly. Blocking NS5A prevents the virus from producing new infectious particles. Dual Mechanism Working together, Daclatasvir and Sofosbuvir reduce viral replication, lower circulating viral levels, and improve the likelihood of achieving a sustained virologic response (SVR), often referred to as a virologic cure. Primecare IMPEX is engaged in supplying pharmaceutical products with a focus on product quality, appropriate documentation, and customer support. Customers value: Quality-focused pharmaceutical products Professional customer assistance Secure packaging Timely communication International supply experience Product documentation support Responsive service Product Specifications Product Name: Myhep DVIR Tablet Generic Name: Daclatasvir 60 mg + Sofosbuvir 400 mg Dosage Form: Film-Coated Tablet Strength: 60 mg / 400 mg Pack Size: 28 Tablets per Bottle Therapeutic Category: Antiviral Medicine Indication: Treatment of Chronic Hepatitis C Virus (HCV) Infection under medical supervision. Frequently Asked Questions (FAQ) What is Myhep DVIR Tablet used for? It is used in the treatment of chronic Hepatitis C Virus infection when prescribed by a qualified healthcare professional. How does Myhep DVIR work? It combines Daclatasvir and Sofosbuvir, two direct-acting antivirals that inhibit different proteins required for HCV replication. Can the tablet be taken with food? Yes. It may generally be taken with or without food, following your healthcare provider's advice. How long is treatment? Treatment duration depends on the patient's condition, viral genotype, liver status, and physician recommendation. Is medical supervision necessary? Yes. This medicine should only be taken under the supervision of a qualified healthcare professional. Contact Primecare IMPEX Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp: https://wa.me/919673008130 Medical Disclaimer This information is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Myhep DVIR Tablet should only be used under the supervision of a qualified healthcare professional and in accordance with approved prescribing information.

MyhepAll Tablet (Sofosbuvir 400 mg + Velpatasvir 100 mg) | Hepatitis C Medicine Guide | Primecare IMPEX arn about MyhepAll Tablet containing Sofosbuvir 400 mg and Velpatasvir 100 mg, its uses, dosage, mechanism of action, safety information, storage, and product profile. Complete patient guide from Primecare IMPEX. MyhepAll Tablet – Sofosbuvir 400 mg + Velpatasvir 100 mg Product Headline MyhepAll Tablet (Sofosbuvir 400 mg + Velpatasvir 100 mg) – Complete Oral Antiviral Therapy for Chronic Hepatitis C Virus (HCV) Infection Product Profile Brand Name: MyhepAll Tablet Generic Name: Sofosbuvir 400 mg + Velpatasvir 100 mg Dosage Form: Film-Coated Tablet Strength: Sofosbuvir 400 mg Velpatasvir 100 mg Packing Size: 28 Tablets (1 Bottle) Therapeutic Category: Direct-Acting Antiviral (DAA) Primary Use: Treatment of Chronic Hepatitis C Virus (HCV) Infection What is MyhepAll Tablet? MyhepAll Tablet is an oral prescription medicine that combines two direct-acting antiviral agents—Sofosbuvir and Velpatasvir. The combination is used for the treatment of chronic hepatitis C virus (HCV) infection in appropriate patients as determined by a qualified healthcare professional. The combination is designed to target different stages of the viral replication process, helping suppress the hepatitis C virus. Treatment duration varies depending on factors such as viral genotype, liver condition, previous treatment history, and the treating clinician's assessment. MyhepAll Tablet is indicated for the treatment of chronic Hepatitis C Virus (HCV) infection in adults and, where approved by local regulations, certain pediatric populations. It may be prescribed for patients with: • Chronic Hepatitis C infection • Multiple HCV genotypes where clinically appropriate • Compensated liver disease • Selected patients with advanced liver disease under specialist supervision • Patients receiving treatment according to current clinical guidelines Healthcare professionals determine treatment duration and whether additional medicines are required based on individual clinical factors. Benefits of MyhepAll Tablet • Once-daily oral administration • Combines two antiviral medicines in one tablet • Targets different stages of viral replication • Used as part of evidence-based HCV treatment protocols • Convenient 28-tablet bottle packaging 2. Mechanism of Action – How MyhepAll Tablet Works Sofosbuvir Sofosbuvir is an NS5B nucleotide polymerase inhibitor. It blocks the viral RNA polymerase enzyme required for hepatitis C virus replication. Without this enzyme, the virus cannot efficiently produce new copies of itself. Velpatasvir Velpatasvir is an NS5A inhibitor. It interferes with viral replication and viral assembly by targeting the NS5A protein, an essential component of the hepatitis C viral life cycle. Dual Mechanism The combination attacks two separate viral targets: • NS5B Polymerase • NS5A Protein This complementary mechanism is why the combination is widely used in modern hepatitis C treatment regimens. Who Should Consult a Doctor Before Taking MyhepAll? Medical consultation is particularly important for individuals with: • Liver disease • Kidney disease • Previous hepatitis treatment • Hepatitis B infection • HIV co-infection • Pregnancy or plans for pregnancy • Breastfeeding • Organ transplantation history Frequently Asked Questions What is MyhepAll Tablet used for? It is a prescription medicine used in the treatment of chronic Hepatitis C Virus (HCV) infection under the supervision of a qualified healthcare professional. How many tablets are in one bottle? One bottle contains 28 tablets. Can it be taken with food? It is generally taken once daily and may be taken with or without food, according to prescribing information and medical advice. Is this a prescription medicine? Yes. MyhepAll Tablet should only be used under the guidance of a qualified healthcare professional. Why Choose Primecare IMPEX? Primecare IMPEX is committed to providing quality pharmaceutical information and reliable customer support. Why people choose Primecare IMPEX: • Patient-focused information • Professional customer assistance • Reliable communication • Transparent product information • International customer support • Timely response to enquiries Contact Primecare IMPEX Primecare IMPEX Business Type Exporter | Supplier | Distributor Website www.medicineexporterfromindia.com Email raakeshkashiwar@gmail.com WhatsApp +91 9673008130 WhatsApp https://wa.me/919673008130

Learn about MydeklaTablet 60 mg containing Daclatasvir Dihydrochloride 60 mg, its approved medical uses, dosage guidance, mechanism of action, safety information, storage instructions, and product details. Use only under the supervision of a qualified healthcare professional. MydeklaTablet 60 mg Daclatasvir Dihydrochloride Tablets 60 mg Product Profile Generic Name: Daclatasvir Dihydrochloride Strength: 60 mg Dosage Form: Oral Tablet Packing: 28 Tablets (1 Bottle) Therapeutic Category: Antiviral Medicine Primary Use: Used as part of combination antiviral therapy for the treatment of chronic Hepatitis C Virus (HCV) infection as prescribed by a physician. What is MydeklaTablet 60 mg? MydeklaTablet 60 mg contains Daclatasvir Dihydrochloride, an antiviral medicine used in combination with other antiviral medicines to treat chronic Hepatitis C Virus (HCV) infection. Daclatasvir is not intended to be used alone and should always be taken according to a healthcare provider's prescription. Modern Hepatitis C treatment aims to eliminate the virus from the body, reduce liver inflammation, prevent progression to cirrhosis, and decrease the risk of liver-related complications. MydeklaTablet 60 mg may be prescribed for adults diagnosed with chronic Hepatitis C infection when used in combination with other antiviral medications selected by the treating physician. Treatment decisions depend on factors including: Hepatitis C genotype Liver function Presence or absence of cirrhosis Previous treatment history Viral load Other existing medical conditions Drug interaction profile Patients should undergo appropriate laboratory evaluation before starting treatment. 2. Mechanism of Action – How Daclatasvir Works Daclatasvir belongs to the class of Direct-Acting Antiviral (DAA) medicines. It works by inhibiting the Hepatitis C virus NS5A protein, which is essential for viral RNA replication and virus assembly. By blocking NS5A activity: Viral replication slows down. New virus particles cannot develop efficiently. Viral levels decrease over the course of treatment. When combined with other direct-acting antivirals, treatment can lead to sustained virologic response (SVR) in many patients, depending on the treatment regimen and individual clinical factors. Is MydeklaTablet 60 mg an antibiotic? No. It is an antiviral medicine used as part of combination therapy for chronic Hepatitis C infection. Can it cure Hepatitis C? Treatment outcomes depend on several clinical factors, including the antiviral regimen, viral genotype, liver condition, adherence to therapy, and the treating physician's recommendations. Can I stop taking the medicine if I feel better? No. Complete the prescribed course unless instructed otherwise by your healthcare provider. Is medical supervision necessary? Yes. This medicine should only be taken under the supervision of a qualified healthcare professional. Why Choose Primecare IMPEX? Primecare IMPEX is an India-based pharmaceutical exporter and supplier offering pharmaceutical products while emphasizing product quality, documentation, and customer support. Contact Primecare IMPEX Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp: https://wa.me/919673008130

SOFOCURE-V (Sofosbuvir 400 mg & Velpatasvir 100 mg) – Complete Product Profile SOFOCURE-V – Sofosbuvir 400 mg and Velpatasvir 100 mg Tablets SOFOCURE-V is an antiviral medicine that contains Sofosbuvir 400 mg and Velpatasvir 100 mg in a fixed-dose combination. It is manufactured under strict quality standards and supplied by Primecare IMPEX, a pharmaceutical exporter from India. The medicine is intended for use only under the supervision of a qualified healthcare professional. Patients should always follow their physician's diagnosis and treatment plan. Product Information Brand Name: SOFOCURE-V Generic Composition: Sofosbuvir 400 mg Velpatasvir 100 mg Dosage Form: Film-Coated Tablets Packing Size: 28 Tablets (1 Bottle) Therapeutic Category: Antiviral Medicine What is SOFOCURE-V? SOFOCURE-V combines two direct-acting antiviral agents that work together to target the hepatitis C virus (HCV). The combination has been developed to help inhibit viral replication through two different mechanisms, supporting effective management of chronic hepatitis C infection in appropriate patients. Treatment decisions should always be individualized by a healthcare professional. How SOFOCURE-V Works SOFOCURE-V combines two antiviral agents with complementary mechanisms of action. Sofosbuvir 400 mg Sofosbuvir is a nucleotide analogue NS5B polymerase inhibitor. It interferes with viral RNA replication by inhibiting the NS5B RNA-dependent RNA polymerase, an enzyme required for hepatitis C virus replication. Velpatasvir 100 mg Velpatasvir inhibits the NS5A protein, which plays an essential role in viral replication and viral assembly. Dual Action The combination targets two separate viral proteins simultaneously. This dual mechanism helps reduce viral replication and supports sustained antiviral activity under physician-guided treatment. Patients should always follow the dosage prescribed by their treating physician. General administration guidance includes: Take one tablet daily if prescribed. Swallow the tablet whole with water. Can be taken with or without food. Take the medicine at approximately the same time each day. Do not crush or chew the tablet. Do not discontinue treatment without medical advice. If a dose is missed, follow the instructions provided by the prescribing physician or product information. Duration of therapy varies depending on the patient's medical condition and should be determined by the healthcare provider. As with any prescription medicine, SOFOCURE-V may cause side effects in some individuals. Commonly reported side effects may include: Headache Fatigue Nausea Weakness Difficulty sleeping Mild gastrointestinal discomfort Patients should seek immediate medical attention if they experience symptoms that are severe, persistent, or unusual. Healthcare professionals may recommend: Liver function tests Viral load monitoring Routine clinical evaluations Review of concurrent medications Assessment of treatment response Patients should inform their healthcare provider about all medicines, supplements, and herbal products they are taking. Why Choose Primecare IMPEX? Primecare IMPEX is committed to providing quality pharmaceutical products with a focus on reliability and professional service. Key strengths include: Quality-focused pharmaceutical sourcing Standardized packaging Careful product handling Timely order processing International shipping support Professional customer assistance Transparent communication Documentation support for export requirements Contact Primecare IMPEX Primecare IMPEX – Pharmaceutical Exporter from India Website www.medicineexporterfromindia.com Email raakeshkashiwar@gmail.com Business Type Exporter | Supplier | Distributor WhatsApp +91 9673008130 WhatsApp https://wa.me/919673008130